Mycobacterial infection: A difficult and late diagnosis in stem cell transplant recipients

Clinical Infectious Diseases

Volumn 38, Issue 9, 2004, Pages 1229-1236

  Cordonnier, C ^a   Martino, R ^b   Trabasso, P ^e   Held, T K ^f   Akan, H ^f   Ward, M S ^h   Fabian, K ⁱ   Ullmann, A J ^g   Wulffraat, N ^j   Ljungman, P ^k   Alessandrino, E P ^l   Pretnar, J ⁿ   Gmur J ^o   Varela, R ^d   Vitek, A ^p   Sica, S ^m   Rovira, M ^c  

^a HENRI MONDOR HOSPITAL   (France)

^b Hospital de la Sant Pau ^*  (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d HOSPITAL JUAN CANALEJO   (Spain)

^e University Hospital   (Brazil)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^h ROYAL PERTH HOSPITAL   (Australia)

ⁱ Szent Laszlo Hospital   (Hungary)

^j UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^k KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^l FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^m CATHOLIC UNIVERSITY   (Italy)

ⁿ University Clinical Centre   (Slovenia)

^o Hematology Oncology Center   (Switzerland)

^p Institute Hematology   (Czech Republic)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; ISONIAZID;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CLINICAL FEATURE; GRAFT VERSUS HOST REACTION; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; MEDICAL INFORMATION; MYCOBACTERIOSIS; MYCOBACTERIUM; PRIORITY JOURNAL; RECIPIENT; REVIEW; STEM CELL TRANSPLANTATION; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; INCIDENCE; MALE; MIDDLE AGED; MULTICENTER STUDY; OPPORTUNISTIC INFECTION; PRESCHOOL CHILD; RETROSPECTIVE STUDY; TUBERCULOSIS;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYCOBACTERIUM INFECTIONS; OPPORTUNISTIC INFECTIONS; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; TUBERCULOSIS;

EID: 2342506450     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/383307     Document Type: Review

References (30)

1. Navari R, Sullivan K, Springmeyer S, et al. Mycobacterial infections in marrow transplant patients. Transplantation 1983; 36:509-13.
2. Kurzrock R, Zander A, Vellekoop L, Kanojia M, Luna M, Dicke K. Mycobacterial pulmonary infections after allogeneic bone marrow transplantation. Am J Med 1984; 77:35-40.
3. Gaviria JM, Garcia PJ, Garrido SM, et al. Nontuberculous mycobacterial infections in hematopoietic stem cell transplant recipients: characteristics of respiratory and catheter-related infections. Biol Blood Marrow Transplant 2000; 6:361-9.
4. Weinstock DM, Feinstein MB, Sepkowitz KA, Jakubowski A. High rates of infection and colonization by nontuberculous mycobacteria after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2003; 31:1015-21.
5. Agerton T, Valway S, Blinkhorn R, et al. Spread of strain W, a highly drug-resistant strain of Mycobacterium tuberculosis, across the United States. Clin Infect Dis 1999; 29:85-92.
6. Salomon N, Perlman D. Editorial response: multidrug-resistant tuberculosis - globally with us for the long haul. Clin Infect Dis 1999; 29:93-5.
7. Young L. Mycobacterial diseases and the compromised host. Clin Infect Dis 1993; 17:S436-41.
8. Singh N, Paterson D. Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Dis 1998; 27:1266-77.
9. Toren A, Ackerstein A, Gazit D, et al. Oral tuberculosis following autologous bone marrow transplantation for Hodgkin's disease with interleukin-2 and alpha-interferon immunotherapy. Bone Marrow Transplant 1996; 18:209-10.
10. Roy V, Weisdorf D. Typical and atypical Mycobacterium. In: Bowden R, Ljungman P, Paya C, eds. Transplant infections. Philadelphia: Lippincott-Raven, 1998:195-201.
11. Keung Y, Nugent K, Jumper C, Cobos E. Mycobacterium tuberculosis infection masquerading as diffuse alveolar hemorrhage afterautologous stem cell transplant. Bone Marrow Transplant 1999; 23:737-8.
12. De La Camara R, Martino R, Granados E, et al. Tuberculosis after hematopoietic stem cell transplantation: incidence, clinical characteristics and outcome. Bone Marrow Transplant 2000; 26:291-8.
13. Ku SC, Tang JL, Hsueh PR, Luh KT, Yu CJ, Yang PC. Pulmonary tuberculosis in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27:1293-7.
14. Arslan O, Gürman G, Dilek I, et al. Incidence of tuberculosis after bone marrow transplantation in as single centre from Turkey. Haematologia 1998; 29:59-62.
15. Martino R, Martinez C, Brunet S, Sureda A, Lopez R, Domingo-Albos A. Tuberculosis in bone marrow transplant recipients: report of two cases and review of the literature. Bone Marrow Transplant 1996; 18:809-12.
16. Ward M, Lam K, Cannell P, Hermann R. Mycobacterial central venous catheter tunnel infection: a difficult problem. Bone Marrow Transplant 1999; 24:325-9.
17. Roy V, Weisdorf D. Mycobacterial infections following bone marrow transplantation: a 20 year retrospective review. Bone Marrow Transplant 1997; 19:467-70.
18. Ip M, Yen K, Chiu E, Chan J, Lam W, Chan T. Pulmonary infections in bone marrow transplantation: the Hong Kong experience. Respiration 1995; 62:80-3.
19. Hale YM, Pfyller GE, Salfinger M. Laboratory diagnosis of mycobacterial infections: new tools and lessons learned. Clin Infect Dis 2001; 33:834-46.
20. Rieder HL, Watson JM, Raviglione MC et al. Surveillance of tuberculosis in Europe. Working Group of the World Health Organization and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting on tuberculosis cases. Eur Respir J 1996; 9:1097-104.
21. Levendoglu-Tugal O, Munoz J, Brudnicki A, Fevzi Ozkaynak M, Sandoval C, Jayabose S. Infections due to nontuberculous mycobacteria in children with leukemia. Clin Infect Dis 1998; 27:1227-30.
22. Straus W, Ostroff S, Jernigan D, et al. Clinical and epidemiological characteristics of Mycobacterium haemophilum, an emerging pathogen in immunocompromised patients. Ann Intern Med 1994; 120:118-25.
23. Jacobson K, Teira R, Libshitz H, et al. Mycobacterium kansasii infections in patients with cancer. Clin Infect Dis 2000; 30:965-9.
24. Lim K, Chong K. Multiple organ failure and septic shock in disseminated tuberculosis. Singapore Med J 1999; 40:176-8.
25. Garyfallou GT. Mycobacterial sepsis following intravesical instillation of bacillus Calmette-Guérin [review]. Acad Emerg Med 1996; 3:157-60.
26. Worku S, Hoft D. In vitro measurement of protective mycobacterial immunity: antigen-specific expansion of T cells capable of inhibiting intracellular growth of bacille Calmette-Guérin. Clin Infect Dis 2000; 30(Suppl 3):S257-61.
27. Jouanguy E, Altare F, Lamhamedi S, et al. Interferon-γ-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N Engl J Med 1996; 335:1956-61.
28. Jouanguy E, Lamhamedi-Cherradi S, Lammas D, et al. A human 1FNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat Genet 1999; 21:370-8.
29. Rouleau M, Senik A, Leroy E, Vernant J. Long-term persistence of transferred PPD-reactive T cells after allogeneic bone marrow transplantation. Transplantation 1993; 55:72-6.
30. Heyderman R, Morgan G, Levinski R, Strobel S. Successful bone marrow transplantation and treatment of BCG infection in two patients with severe combined immunodeficiency. Eur J Pediatr 1991; 150:477-80.